Tanshinone IIA Promotes Functional Recovery After Spinal Cord Injury by Inhibiting Neuron and Oligodendrocyte Ferroptosis Through the GPX4/ACSL4 Axis
- 16 May 2025
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 50 (3) , 1-12
Abstract
Spinal cord injury (SCI) induces severe functional impairments and involves intricate secondary injury mechanisms. Tanshinone IIA (TIIA), a key bioactive component of Salvia miltiorrhiza, exhibits neuroprotective potential, yet its role in ferroptosis regulation post-SCI remains undefined. This study explored the protective effects and underlying mechanisms of TIIA in SCI. In a rat SCI model, TIIA markedly enhanced hind limb motor function and preserved histopathological integrity while mitigating mitochondrial damage, ferroptosis, and oxidative stress. TIIA attenuated ferroptosis by reducing reactive oxygen species (ROS), malondialdehyde (MDA), and acyl-CoA synthetase long-chain family member 4 (ACSL4) while elevating glutathione (GSH), superoxide dismutase (SOD), and glutathione peroxidase 4 (GPX4) levels. Mechanistically, TIIA suppressed ferroptosis through modulation of the GPX4/ACSL4 axis. The ferroptosis inducer RSL3 abrogated these protective effects, further validating this mechanism. These findings highlight the therapeutic potential of TIIA in SCI by targeting the GPX4/ACSL4 pathway to attenuate ferroptosis and promote functional recovery.Keywords
Funding Information
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81804119, No. 81973882)
- the Central High-Level Clinical Research Fund for Traditional Chinese Medicine Hospitals (DZMG-QNGG0010)
- Fundamental Research Funds for the Central Universities (2024-JYB-JBZD-065)
This publication has 61 references indexed in Scilit:
- Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injuryPLOS ONE, 2022
- Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trialsThe Lancet Neurology, 2022
- Epidemiology of Traumatic Spinal Cord Injury in Developing Countries from 2009 to 2020: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2022
- Epidemiology of traumatic spinal cord injury: a large population-based studySpinal Cord, 2022
- Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord InjuryJournal of Inflammation Research, 2022
- Cell transplantation and secretome based approaches in spinal cord injury regenerative medicineMedicinal Research Reviews, 2021
- Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury modelJournal of Translational Medicine, 2018
- Tanshinone IIA improves functional recovery in spinal cord injury-induced lower urinary tract dysfunctionNeural Regeneration Research, 2017
- A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in RatsJournal of Neurotrauma, 1995
- Objective clinical assessment of motor function after experimental spinal cord injury in the ratJournal of Neurosurgery, 1977